Echo Therapeutics Inc fka ECTE

[ramad]

That is a hard call easy money. If echo's terms if funding is the same as the previous The whisper number for the new round of financing is anywhere from $4 to $5 million their would be a dilution of about 15 million shares and 15 million warrants which would be about 100% fully diluted. From 30M to around 60M fully diluted.

Secondly, the most important factor is when will echo have a product on the market to receive revenue. At the present time MTIA has no workable CGM to go forward with clinical trials. If and when they do is anyone's guess at this time.The new model echo is currently working on is months away before they could start clinical trials for FDA approval and most likely only get approval in the latter part of 2017. Echo has not made any announcement as to why MTIA has not started clinical trial which does not bode well for any immediate CFDA approval for the next 3 to 4 months.

Therefore with a big dilution, no imminent product to receive revenue a few hundred thousand shares and options that can be sold, no CEO I would not jump in on any announcement echo makes unless they can guarantee when the clinical trials will start and I do not believe they will or even know when they close the deal. If and when they ever get to clinical trials be it CFDA or FDA that is when I believe
The value of the company will rise accordingly. Anyone buying today is taking a crap shot. Either it's a bust or it will be a block buster as some of the biotech stocks. It's anyone's guess without any CEO giving the shareholders a road map or any info the stock price is forcasting bankruptcy.
In my opinion instead of going out to dinner I would take a shot. In both cases at the end of the day you end up having nothing of value if the company does not have a product to sell and if they are successful you can laugh all the way to the bank.